IRIS
MAZZONE, ELIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.475
NA - Nord America 2.157
AS - Asia 1.616
SA - Sud America 316
Continente sconosciuto - Info sul continente non disponibili 120
AF - Africa 48
OC - Oceania 4
Totale 6.736
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.999
RU - Federazione Russa 1.228
CN - Cina 536
IT - Italia 473
SG - Singapore 463
BR - Brasile 255
HK - Hong Kong 207
SE - Svezia 200
DE - Germania 191
VN - Vietnam 159
CA - Canada 95
FR - Francia 76
GB - Regno Unito 69
NL - Olanda 60
FI - Finlandia 57
BD - Bangladesh 54
IN - India 51
MX - Messico 28
ES - Italia 27
JP - Giappone 22
PL - Polonia 21
AR - Argentina 18
IQ - Iraq 16
EG - Egitto 14
ZA - Sudafrica 14
CH - Svizzera 13
EC - Ecuador 13
PH - Filippine 13
ID - Indonesia 12
MY - Malesia 12
TR - Turchia 11
AT - Austria 10
LT - Lituania 10
BE - Belgio 9
CR - Costa Rica 8
PK - Pakistan 8
MA - Marocco 7
VE - Venezuela 7
IR - Iran 6
KR - Corea 6
PT - Portogallo 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
IE - Irlanda 5
PE - Perù 5
PY - Paraguay 5
UA - Ucraina 5
CL - Cile 4
GT - Guatemala 4
HN - Honduras 4
NI - Nicaragua 4
NP - Nepal 4
TW - Taiwan 4
AU - Australia 3
DZ - Algeria 3
IL - Israele 3
KH - Cambogia 3
NG - Nigeria 3
SN - Senegal 3
SV - El Salvador 3
UY - Uruguay 3
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
GR - Grecia 2
HT - Haiti 2
JM - Giamaica 2
LB - Libano 2
MD - Moldavia 2
PR - Porto Rico 2
RO - Romania 2
UZ - Uzbekistan 2
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CD - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
GE - Georgia 1
GF - Guiana Francese 1
GP - Guadalupe 1
KE - Kenya 1
KW - Kuwait 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LV - Lettonia 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TG - Togo 1
TH - Thailandia 1
TN - Tunisia 1
Totale 6.616
Salva come PNG Salva come JPEG
Città #
Ashburn 311
Singapore 261
Moscow 219
San Jose 197
Hong Kong 187
Dallas 163
Milan 135
New York 122
Shanghai 100
Beijing 91
Council Bluffs 88
Los Angeles 66
Ho Chi Minh City 60
Hefei 57
Lauterbourg 50
Santa Clara 47
Princeton 44
Lawrence 42
Munich 37
Hanoi 36
Phoenix 32
Irvine 30
Montreal 28
Rome 27
Helsinki 25
Boardman 24
Orem 24
Tokyo 22
Turku 22
Denver 20
Frankfurt am Main 20
Chennai 19
São Paulo 19
Brooklyn 17
Buffalo 16
Chicago 16
Amsterdam 15
Atlanta 15
Stockholm 15
Warsaw 15
Da Nang 13
Naples 13
London 12
Manchester 12
Miano 12
Boston 11
Nuremberg 11
Palermo 11
Toronto 11
Guangzhou 10
Seattle 10
Houston 9
Johannesburg 9
Mexico City 9
San Francisco 9
Turin 9
Brescia 8
Cairo 8
Hung Hom 8
Memphis 8
Mumbai 8
Rio de Janeiro 8
North Bergen 7
Pune 7
Baghdad 6
Barnet 6
Belo Horizonte 6
Brasília 6
Dalian 6
Guayaquil 6
Hamilton 6
Istanbul 6
Lappeenranta 6
Lausanne 6
Querétaro 6
San José 6
Tianjin 6
Vancouver 6
Vienna 6
Washington 6
Alexandria 5
Bennekom 5
Brussels 5
Columbus 5
Kuala Lumpur 5
Las Vegas 5
Lisbon 5
Miami 5
Nanyang 5
New Delhi 5
Ankara 4
Biên Hòa 4
Bologna 4
Borås 4
Campinas 4
Changsha 4
Curitiba 4
Guatemala City 4
Jiaxing 4
Lahore 4
Totale 3.153
Salva come PNG Salva come JPEG
Nome #
INTEGRATING PSMA EXPRESSION PATTERNS, MORPHOLOGICAL AND CLINICAL FEATURES TO OPTIMIZE DETECTION OF NODAL METASTASES IN PATIENTS TREATED WITH PSMA RADIO-GUIDED ROBOT-ASSISTED RADICAL PROSTATECTOMY AND EXTENDED PELVIC LYMPH NODE DISSECTION 412
Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy 272
The Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Assessment of Local Recurrence and Distant Metastases in Patients with Biochemical Recurrence of Prostate Cancer After Definitive Treatment: A Systematic Review and Meta-analysis 246
A NOVEL MODEL INTEGRATING CLINICAL, MP-MRI, AND EPIGENOMIC FEATURES TO PREDICT LYMPH NODE INVASION IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION 188
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 175
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series 174
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard 164
Survival Effect of Nephroureterectomy in Metastatic Upper Urinary Tract Urothelial Carcinoma 148
Contemporary Techniques of Prostate Dissection for Robot-assisted Prostatectomy 143
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 138
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? 138
Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study 136
Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis 134
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study 133
Does previous prostate surgery affect multiparametric magnetic resonance imaging accuracy in detecting clinically significant prostate cancer? Results from a single institution series 132
Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer 127
Optimizing prostate-targeted biopsy schemes in men with multiple mpMRI visible lesions: should we target all suspicious areas? Results of a two institution series 127
Impact of prostate MRI central review over the diagnostic performance of MRI-targeted biopsy: should we routinely ask for an expert second opinion? 126
Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters 124
A Comprehensive Systematic Review and Meta-analysis of the Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Diagnosis and Primary Staging before Definitive Treatment 124
Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought 122
Assessing the need for systematic biopsies in addition to targeted biopsies according to the characteristics of the index lesion at mpMRI. Results from a large, multi-institutional database 116
The effect of frailty on post-operative outcomes and health care expenditures in patients treated with partial nephrectomy 116
Association Between Multiparametric Magnetic Resonance Imaging of the Prostate and Oncological Outcomes after Primary Treatment for Prostate Cancer: A Systematic Review and Meta-analysis 116
Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate Cancer 110
ASSOCIATION BETWEEN POLYMORPHISMS OF HOMOLOGOUS RECOMBINATION RAD51B AND DISEASE RECURRENCE IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY 107
Reducing the Risk of Postoperative Complications After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients: Results of an Audit and Feedback Intervention Following the Implementation of Prospective Data Collection 105
Development and Validation of a Lookup Table for the Prediction of Metastatic Prostate Cancer According to Prostatic-specific Antigen Value, Clinical Tumor Stage, and Gleason Grade Groups 102
Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer: results from a surgical series at a high-volume institution 102
Effect of external beam radiotherapy on second primary cancer risk after radical prostatectomy 101
Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal Therapy 100
Assessing the Best Surgical Template at Salvage Pelvic Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: When Can Bilateral Dissection be Omitted? Results from a Multi-institutional Series 100
Tailored use of PSA density according to multiparametric MRI index lesion location: results of a large, multi-institutional series 96
Adherence to Guideline Recommendations for Perioperative Chemotherapy in Patients with pN2-3 M0 Squamous Cell Carcinoma of the Penis: Temporal Trends and Survival Outcomes 94
Conditional survival of patients with stage I–III squamous cell carcinoma of the penis: temporal changes in cancer-specific mortality 93
Risk Stratification of Patients Candidate to Radical Prostatectomy Based on Clinical and Multiparametric Magnetic Resonance Imaging Parameters: Development and External Validation of Novel Risk Groups 93
Contemporary analysis of the effect of marital status on survival of prostate cancer patients across all stages: A population-based study 92
A Plea for Optimizing Selection in Current Adjuvant Immunotherapy Trials for High-risk Nonmetastatic Renal Cell Carcinoma According to Expected Cancer-specific Mortality 88
Utility of MRI perilesional biopsy in prostate cancer: impact of the Prostate Imaging-Reporting and Data System and biopsy history 85
Contemporary clinicopathological characteristics of pT0 prostate cancer at radical prostatectomy: A population-based study 85
Adherence to guideline recommendations for lymph node dissection in squamous cell carcinoma of the penis: Effect on survival and complication rates 84
Comparison of perioperative outcomes between open and minimally invasive nephroureterectomy: A population-based analysis 84
Contemporary Comparison of Clinicopathologic Characteristics and Survival Outcomes of Prostate Ductal Carcinoma and Acinar Adenocarcinoma: A Population-Based Study 77
Contemporary trends of pelvic lymph node dissection at radical cystectomy for urothelial carcinoma of urinary bladder and associated cancer specific mortality and complications: comparison between octogenarian versus younger patients 75
The effect of race on survival after local therapy in metastatic prostate cancer patients 72
Optimising the selection of candidates for neoadjuvant chemotherapy amongst patients with node-positive penile squamous cell carcinoma 70
Impact of Obesity on Perioperative Outcomes at Robotic-assisted and Open Radical Prostatectomy: Results From the National Inpatient Sample 70
Initial Experience with Radical Prostatectomy Following Holmium Laser Enucleation of the Prostate 70
Postoperative paralytic ileus after major oncological procedures in the enhanced recovery after surgery era: A population based analysis 70
Survival Effect of Chemotherapy in Metastatic Upper Urinary Tract Urothelial Carcinoma 68
Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer. Letter 67
Nephroureterectomy with or without Bladder Cuff Excision for Localized Urothelial Carcinoma of the Renal Pelvis 64
Impact of Tumor Size on Cancer-Specific Mortality Rate after Local Tumor Ablation in T1a Renal-Cell Carcinoma 64
Survival effect of perioperative systemic chemotherapy on overall mortality in locally advanced and/or positive regional lymph node non-metastatic urothelial carcinoma of the upper urinary tract 62
Temporal trends and social barriers for inpatient palliative care delivery in metastatic prostate cancer patients receiving critical care therapies 62
Rates of lymph node invasion and their impact on cancer specific mortality in upper urinary tract urothelial carcinoma 55
Primary lymphomas of the genitourinary tract: A population-based study 54
Partial Cystectomy With Pelvic Lymph Node Dissection for Patients With Nonmetastatic Stage pT2-T3 Urothelial Carcinoma of Urinary Bladder: Temporal Trends and Survival Outcomes 50
Trends and social barriers for inpatient palliative care in patients with metastatic bladder cancer receiving critical care therapies 48
Added Value of Prostate-specific Antigen Density in Selecting Prostate Biopsy Candidates Among Men with Elevated Prostate-specific Antigen and PI-RADS ≥3 Lesions on Multiparametric Magnetic Resonance Imaging of the Prostate: A Systematic Assessment by PI-RADS Score 31
One year in: early European adoption of the da Vinci Single Port platform—a multi-institutional study from the European Association of Urology Robotic Urology Section Scientific Working Group 21
PSMA Radio-guided Surgery to Identify Lymph Node Metastases in Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Phase 2 Prospective Study 15
Not All Adverse Pathology Features Are Equal: Identifying Optimal Candidates for Adjuvant Radiotherapy among Patients with Adverse Pathology at Radical Prostatectomy 7
PD35-02 WHEN IS NEOADJUVANT ANDROGEN DEPRIVATION THERAPY BENEFICIAL FOR HIGHLY AGGRESSIVE PROSTATE CANCER CANDIDATES TO RADICAL PROSTATECTOMY? IMPLICATIONS FOR MULTI-MODAL TAILORED APPROACHES AND TRIALS DESIGN 6
PD35-01 WHICH PATIENTS WITH CN1 DISEASE AT PET/CT ARE AFFECTED BY SYSTEMIC DISEASE? IMPLICATIONS FOR TAILORED TREATMENT APPROACHES BASED ON A LARGE MULTI-INSTITUTIONAL SERIES 5
null 1
Totale 6.736
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.291
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.291
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202235 0 0 0 18 0 3 1 1 0 0 0 12
2022/2023322 109 73 29 13 5 33 7 27 13 0 6 7
2023/2024396 2 18 38 22 28 88 6 38 6 38 45 67
2024/20251.172 104 52 40 100 64 117 183 116 108 82 89 117
2025/20263.829 240 234 186 441 312 108 278 361 1.084 261 177 147
2026/2027943 140 196 206 401 0 0 0 0 0 0 0 0
Totale 6.736